Clinical Trial Update: A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 study of QLH2405 in healthy participants and in participants with mild cognitive impairment due to Alzheimer's disease and mild Alzheimer's disease; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• QLH2405

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI) | Phase 1 | Status: NOT_YET_RECRUITING